Pendal Group Ltd trimmed its stake in Humana Inc (NYSE:HUM) by 14.1% during the third quarter, Holdings Channel reports. The fund owned 86,379 shares of the insurance provider’s stock after selling 14,170 shares during the period. Pendal Group Ltd’s holdings in Humana were worth $29,241,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. Gulf International Bank UK Ltd boosted its position in shares of Humana by 4.5% in the third quarter. Gulf International Bank UK Ltd now owns 46,421 shares of the insurance provider’s stock worth $15,714,000 after buying an additional 2,000 shares during the period. Mn Services Vermogensbeheer B.V. boosted its position in shares of Humana by 2.8% in the third quarter. Mn Services Vermogensbeheer B.V. now owns 22,336 shares of the insurance provider’s stock worth $7,561,000 after buying an additional 600 shares during the period. Virginia Retirement Systems ET AL boosted its position in shares of Humana by 358.2% in the third quarter. Virginia Retirement Systems ET AL now owns 30,700 shares of the insurance provider’s stock worth $10,393,000 after buying an additional 24,000 shares during the period. WINTON GROUP Ltd boosted its position in shares of Humana by 4.7% in the third quarter. WINTON GROUP Ltd now owns 86,054 shares of the insurance provider’s stock worth $29,131,000 after buying an additional 3,855 shares during the period. Finally, WESPAC Advisors LLC acquired a new stake in shares of Humana in the third quarter worth $746,000. 92.62% of the stock is owned by institutional investors and hedge funds.
In other Humana news, insider Elizabeth D. Bierbower sold 3,092 shares of the business’s stock in a transaction dated Thursday, August 16th. The stock was sold at an average price of $330.00, for a total value of $1,020,360.00. Following the completion of the sale, the insider now owns 14,289 shares of the company’s stock, valued at $4,715,370. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Bruce D. Broussard sold 18,000 shares of the business’s stock in a transaction dated Monday, September 10th. The stock was sold at an average price of $328.66, for a total value of $5,915,880.00. Following the completion of the sale, the chief executive officer now directly owns 71,085 shares of the company’s stock, valued at approximately $23,362,796.10. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by company insiders.
Several brokerages have recently commented on HUM. Zacks Investment Research cut Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, August 8th. Piper Jaffray Companies raised their target price on Humana from $355.00 to $380.00 and gave the stock an “overweight” rating in a research report on Friday, August 24th. Argus raised their target price on Humana to $375.00 and gave the stock a “buy” rating in a research report on Tuesday, September 4th. Jefferies Financial Group raised their target price on Humana from $356.00 to $372.00 and gave the stock a “buy” rating in a research report on Thursday, August 2nd. Finally, Morgan Stanley began coverage on Humana in a research report on Thursday, July 12th. They issued an “overweight” rating and a $362.00 target price for the company. Seven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Humana currently has an average rating of “Buy” and a consensus price target of $339.79.
HUM opened at $326.61 on Tuesday. The firm has a market cap of $44.50 billion, a P/E ratio of 27.89, a PEG ratio of 1.61 and a beta of 1.03. Humana Inc has a 1 year low of $231.90 and a 1 year high of $341.30. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.47.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 25th. Investors of record on Monday, December 31st will be given a dividend of $0.50 per share. The ex-dividend date is Friday, December 28th. This represents a $2.00 dividend on an annualized basis and a yield of 0.61%. Humana’s payout ratio is 17.08%.
COPYRIGHT VIOLATION WARNING: “Pendal Group Ltd Sells 14,170 Shares of Humana Inc (HUM)” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/11/06/pendal-group-ltd-sells-14170-shares-of-humana-inc-hum.html.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Featured Story: What are Institutional Investors?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.